Epilepsy affects millions globally, with on-going research exploring potential new treatments beyond conventional medication. One emerging area of interest is CBD (cannabidiol), a compound derived from the cannabis plant that has shown promise in managing epilepsy symptoms for certain types of seizures. Below, we’ll answer some common questions on how CBD might help those with epilepsy, its availability in the UK, and whether it’s accessible through the NHS.
CBD has become increasingly popular as a complementary therapy for epilepsy, especially for those with drug-resistant types. Unlike THC (the psychoactive compound in cannabis), CBD does not cause a “high,” and it works by interacting with the body’s endocannabinoid system, which influences various functions including sleep, mood, and potentially seizure regulation.
Some studies have found CBD to be beneficial for people with epilepsy, particularly with severe types like Dravet syndrome and Lennox-Gastaut syndrome. Some cases have shown it to reduce seizure frequency and severity, providing hope to those who may not respond well to traditional treatments. However, anyone considering CBD should consult their doctor first, as it may interact with certain anti-seizure medications.
Researchers in the UK are investigating the potential benefits of CBD oil for epilepsy, and the initial findings are promising. Researchers have linked the active compound, CBD, to a reduction in seizures, particularly in drug-resistant epilepsy cases where other medications have had limited success. One of the more extensively researched treatments for severe forms of epilepsy is Epidyolex, a purified form of CBD.
Individuals in the UK can use CBD oil as a complementary approach to managing epilepsy, but they should use it under medical supervision. Quality and dosage can vary across products, so it’s essential to select CBD from reputable sources that offer clear information on their content and dosing guidelines.
Yes, but with limitations. Currently, the NHS provides CBD-based medication only in very specific cases. The FDA has approved Epidyolex, a prescription drug containing CBD, to treat seizures in patients with Dravet syndrome and Lennox-Gastaut syndrome, two rare and severe forms of epilepsy. This approval came after clinical trials demonstrated its effectiveness in reducing seizure frequency and improving the quality of life for patients with these conditions.
For most other types of epilepsy, CBD oil is not generally available through an NHS prescription. However, patients interested in exploring CBD options should discuss it with their healthcare provider to determine whether it’s a safe and viable option for them. They can also explore the possibility of using regulated CBD products available legally in the UK, which don’t require a prescription but still demand careful selection and responsible use.
Researchers are exploring CBD’s potential in treating epilepsy, finding evidence to support its use in certain severe cases. Some people, particularly those with drug-resistant forms of epilepsy, have shown that CBD, while not a cure, can help reduce seizure frequency and severity. The NHS offers the prescription drug Epidyolex for specific types of epilepsy, but most people seek CBD treatments privately.
As research continues, CBD may become a more widely accepted treatment option for managing epilepsy. In the meantime, anyone considering CBD for epilepsy should consult their healthcare provider to understand the best approach, as well as any risks or interactions with existing medications.